✦ LIBER ✦

Delay in the progression of low-risk prostate cancer: Rationale and design of the Reduction by Dutasteride of Clinical Progression Events in Expectant Management (REDEEM) trial

✍ Scribed by Neil Fleshner; Leonard G. Gomella; Michael S. Cookson; Antonio Finelli; Andrew Evans; Samir S. Taneja; M. Scott Lucia; Eric Wolford; Matthew C. Somerville; Roger Rittmaster

Book ID: 116350671
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 141 KB
Volume: 28
Category: Article
ISSN: 1551-7144
DOI: 10.1016/j.cct.2007.05.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

78 EFFECT OF BASELINE CHARACTERISTICS ON

78 EFFECT OF BASELINE CHARACTERISTICS ON RELATIVE RISK OF PROSTATE CANCER PROGRESSION IN THE REDUCTION BY DUTASTERIDE OF CLINICAL PROGRESSION EVENTS IN EXPECTANT MANAGEMENT (REDEEM) TRIAL

✍ N.E. Fleshner; M.S. Lucia; B. Egerdie; L. Black; K. Melich; I. Nandy; R. Rittmas 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 258 KB

2109 UTILITY OF PSA IN THE REDUCTION BY

2109 UTILITY OF PSA IN THE REDUCTION BY DUTASTERIDE OF CLINICAL PROGRESSION EVENTS IN EXPECTANT MANAGEMENT OF PROSTATE CANCER (REDEEM) STUDY

✍ Fleshner, Neil; Margel, David; Wilson, Timothy H.; Castro, Ramiro 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 189 KB

The REDUCE trial (REduction by DUtasteri

The REDUCE trial (REduction by DUtasteride of prostate Cancer Events) — rationale and study design

✍ Gerald Andriole; Michael Marberger; Roger S Rittmaster 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 84 KB

CHEMOPREVENTION OF PROSTATE CANCER IN ME

CHEMOPREVENTION OF PROSTATE CANCER IN MEN AT HIGH RISK: RATIONALE AND DESIGN OF THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) TRIAL

✍ ANDRIOLE, G; BOSTWICK, D; BRAWLEY, O; GOMELLA, L; MARBERGER, M; TINDALL, D; BREE 📂 Article 📅 2004 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 163 KB

Serum Testosterone and Dihydrotestostero

Serum Testosterone and Dihydrotestosterone and Prostate Cancer Risk in the Placebo Arm of the Reduction by Dutasteride of Prostate Cancer Events Trial

✍ Roberto L. Muller; Leah Gerber; Daniel M. Moreira; Gerald Andriole; Ramiro Castr 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 345 KB

7006 Effect of baseline characteristics

7006 Effect of baseline characteristics on prostate cancer rates and risk reduction in the Reduction by Dutasteride of prostate Cancer Events REDUCE) trial

✍ Andriole, G.; Brawley, O.; Gomella, L.; Marberger, M.; Montorsi, F.; Pettaway, C 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 69 KB